Nara, Japan

Hiromasa Araki

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Fuso Pharmaceutical Industries, Ltd.. Active years: 2000-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromasa Araki. Retrieved from https://idiyas.com/inventor/hiromasa-araki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Osaka, JP (2000)
  • Yamatokaoriyama, JP (2008)
  • Nara, JP (2005 - 2009)

Company Filing History:


Years Active: 2000-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hiromasa Araki: Innovator in Digestive Health and Lacrimal Secretion

Introduction

Hiromasa Araki is a notable inventor based in Nara, Japan. He has made significant contributions to the fields of digestive health and lacrimal secretion through his innovative patents. With a total of four patents to his name, Araki's work focuses on developing compositions that address critical health issues.

Latest Patents

Araki's latest patents include a composition for preventing and treating diseases of the digestive organs. This invention provides a safe and effective method for addressing conditions such as gastric ulcers, duodenal ulcers, gastritis, diarrhea, and enteritis. The composition features a novel mechanism of action that overcomes challenges associated with previously known side effects. Specifically, it includes an ingredient that activates PAR-2, which is essential for inhibiting gastric acid secretion, promoting mucus secretion in the digestive tract, protecting the mucosa, and repairing tissue in digestive organs.

Another significant patent by Araki is a composition for promoting lacrimal secretion. This invention offers a safe and effective alternative for lacrimal secretion therapy, moving beyond conventional supplemental therapies. The composition also contains a component that activates PAR-2 and includes a contact lens designed to retain or contain the composition for promoting lacrimal secretion.

Career Highlights

Hiromasa Araki is associated with Fuso Pharmaceutical Industries, Ltd., where he continues to innovate in the pharmaceutical field. His work has garnered attention for its potential to improve patient outcomes in digestive health and eye care.

Collaborations

Araki has collaborated with notable colleagues, including Atsufumi Kawabata and Shuichi Tanaka. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Hiromasa Araki's contributions to the fields of digestive health and lacrimal secretion exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving health outcomes through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…